100
Views
2
CrossRef citations to date
0
Altmetric
LETTERS

Accelerated Phase at Initial Presentation in Chédiak-Higashi Syndrome: Is It Really Uncommon ?

, , , &
Pages 382-385 | Received 18 Jul 2013, Accepted 21 Sep 2013, Published online: 25 Nov 2013

REFERENCES

  • Ahluwalia J, Pattari S, Trehan A, Accelerated phase at initial presentation: an uncommon occurrence in Chédiak-Higashi syndrome. Pediatr Hematol Oncol. 2003;20:563–567.
  • Nargund AR, Madhumathi DS, Premalatha CS, Accelerated phase of Chediak-Higashi syndrome mimicking lymphoma: a case report. J Pediatr Hematol Oncol. 2010;32:e223–e226.
  • Merino F, Henle W, Ramirez-Duque P. Chronic active Epstein- Barr virus infection in patients with Chediak-Higashi syndrome. J Clin Immunol. 1986;6:299–305.
  • Mehdizadeh M, Zamani G. Griscelli syndrome: a case report. Pediatr Hematol Oncol. 2007; 24:525–529.
  • Cahali JB, Fernandez SA, Oliveira ZN, Machado MC, Valente NS, Sotto MN. Elejalde syndrome: report of a case and review of the literature. Pediatr Dermatol. 2004;21:479–482.
  • Ahluwalia J, Kumar V, Trehan A, The psuedo-Chediak-Higashi anomaly: an unusual staining pattern in an Indian child with acute myeloid leukemia. Pediatr Hematol Oncol. 2004;21:199–202.
  • Gordon N, Mullen CA, Tran H, Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome. J Pediatr Hematol Oncol. 2003;25:824–826.
  • Baldus M, Zunftmeister V, Geibel-Werle G, Chédiak-Higashi-Steinbrinck syndrome (CHS) in a 27-year-old woman–effects of G-CSF treatment. Ann Hematol. 1999;78:321–327.
  • Möttönen M, Lanning M, Saarinen UM. Allogeneic bone marrow transplantation in Chédiak-Higashi syndrome. Pediatr Hematol Oncol. 1995;12:55–59.
  • Roy A, Kar R, Basu D, Clinico-hematological profile of Chédiak-Higashi syndrome: Experience form a tertiary care center in south India. Indian J Pathol Microbiol. 2011;54:547–551.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.